LogoThe Drop In by DoubleBlind
Upgrade
Subscribe Now
LogoThe Drop In by DoubleBlind

Archive

Mail-Order Ketamine Injections are Now a Thing

Jan 31, 2025

•

2 min read

Mail-Order Ketamine Injections are Now a Thing

Welcome to the wild world of ketamine therapy

Mattha Busby
Mattha Busby
💧Ayahuasca in Peru? US Embassy says no

Jan 30, 2025

•

16 min read

💧Ayahuasca in Peru? US Embassy says no

PLUS, can you really stop a bad trip?

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Unlock Blue Lotus’s secrets for lucid dreaming

Jan 29, 2025

•

16 min read

Unlock Blue Lotus’s secrets for lucid dreaming

Curious about Blue Lotus? 🌙 This ancient flower sparks vivid dreams and promotes relaxation. Explore its history, benefits, and how to use it.

Sian Seligman
Sian Seligman
💧Silk Road Founder Freed + MAPS Cannabis Research

Jan 27, 2025

•

14 min read

💧Silk Road Founder Freed + MAPS Cannabis Research

Trump pardons Silk Road's Ross Ulbricht, while MAPS accelerates cannabis trials for PTSD treatment.

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Amsterdam’s Last Shroom Lounge Is Hiding in Plain Sight

Jan 26, 2025

•

11 min read

Amsterdam’s Last Shroom Lounge Is Hiding in Plain Sight

This hidden gem has been a sanctuary for trippers for decades, but stricter policies threaten its survival. What does this mean for Amsterdam’s psychedelic legacy?

Michelle Lhooq
Michelle Lhooq
Trump and the Future of Psychedelics

Jan 24, 2025

•

2 min read

Trump and the Future of Psychedelics

RFK Jr. and Elon Musk allies are rallying behind reform, but not everyone is onboard

Jack Gorsline
Jack Gorsline
💧 Visionary nail art á la Alex Grey

Jan 23, 2025

•

15 min read

💧 Visionary nail art á la Alex Grey

From canvas to cuticle, one nail artist recreates the Greys’ visionary art and the details about Naropa’s split with its Center for Psychedelic Studies.

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
Did the FDA destroy the psychedelic medicine movement?

Jan 22, 2025

•

14 min read

Did the FDA destroy the psychedelic medicine movement?

MDMA once stole the spotlight, but it’s since taken a seat on the sideline after the FDA’s rejection last August. So now what?

Reilly Capps
Reilly Capps
💧 Wellness influencers and ethics in times of crisis

Jan 20, 2025

•

10 min read

💧 Wellness influencers and ethics in times of crisis

From detox kits to raw milk, influencers are cashing in on LA’s wildfire tragedy. What’s genuine care and what’s a sales pitch?

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 Who steps up when LA is on fire?

Jan 16, 2025

•

13 min read

💧 Who steps up when LA is on fire?

Here’s how the psychedelic community is responding to tragedy

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 CIA releases 1200 documents on LSD-brainwashing program

Jan 13, 2025

•

14 min read

💧 CIA releases 1200 documents on LSD-brainwashing program

PLUS, the neuromeme dominating the psychedelic renaissance

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
💧 The Feds crack down on Amanita. Here’s what it means

Jan 9, 2025

•

16 min read

💧 The Feds crack down on Amanita. Here’s what it means

PLUS, MDMA for traumatized dogs?

Mary Carreón // Editor-in-Chief
Mary Carreón // Editor-in-Chief
1...2021222324...28
The Drop In by DoubleBlind

The Drop In by DoubleBlind

Your essential newsletter covering the world of psychedelics. Trusted by 100k+ readers.


Home

Account